PP

Peter Prabhu Paul Rajendran

Active Director Director DIN 07404576
DIN 07404576 First appointment Jul 2016 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Peter Prabhu Paul Rajendran

Data last updated:

Peter Prabhu Paul Rajendran is a Director at I-Spec Critical Care Private Limited (since 2016). The company operates in Trading.

DIN 07404576
Primary Designation Director
Industry Trading
First Appointment 13 Jul 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
I-Spec Critical Care Private Limited U51101KA2016PTC085802
Director13 Jul 20162016Active

Board colleagues of Peter Prabhu Paul Rajendran

Directorship timeline

Open interactive timeline →
I-Spec Critical Care Private Limited
Premium access

Shareholding and investment profile for Peter Prabhu Paul Rajendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peter Prabhu Paul Rajendran

Peter Prabhu Paul Rajendran currently holds 1 directorship: I-Spec Critical Care Private Limited (Director, since 13 Jul 2016).

Peter Prabhu Paul Rajendran was first appointed on 13 Jul 2016 as Director at I-Spec Critical Care Private Limited.

The current boards of Peter Prabhu Paul Rajendran's companies include Kubendran Kandaswamy (I-Spec Critical Care Private Limited), Marimuthu Kamarajan Vadivukkarasi (I-Spec Critical Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available